Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19. Somersan-Karakaya S, Mylonakis E, Menon VP, Wells JC, et al. J Infect Dis 2022;227:23-34.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Somersan-Karakaya S, Mylonakis E, Menon VP, Wells JC, et al. Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19. J Infect Dis 2022;227:23-34.
PMID: 35895508